Kedrion

Overview

  • Founded in 2001
  • Headquartered in Barga, Italy
  • 1,250 employees

Visit Site

Kedrion is a biopharmaceutical company specializing in the development, production and distribution of plasma-derived products.  Kedrion was formed after a series of mergers and acquisitions, through which it acquired a heritage of expertise that secured its prominent role in Italy’s biotech industry.

Kedrion has partnered with Italy’s National Health Service and major medical institutions around the globe on the production of plasma-derived medicinal products.

Financials

  • 2010 sales: €248 million

Management Team

  • Paolo Marcucci: President and CEO

Contact